Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults

INTRODUCTION: Dupilumab significantly improves signs and symptoms of atopic dermatitis (AD), including pruritus, symptoms of anxiety and depression, and health-related quality of life versus placebo in adults with moderate-to-severe AD. Since the cost-effectiveness of dupilumab has not been evaluate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Dermatol Ther (Heidelb)
Hauptverfasser: Kuznik, Andreas, Bégo-Le-Bagousse, Gaëlle, Eckert, Laurent, Gadkari, Abhijit, Simpson, Eric, Graham, Christopher N., Miles, LaStella, Mastey, Vera, Mahajan, Puneet, Sullivan, Sean D.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Healthcare 2017
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5698200/
https://ncbi.nlm.nih.gov/pubmed/28933010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13555-017-0201-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge